Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitroglycerin for peripheral perfusion in hemorrhagic shock
NCT03235921Phase 2Unknown
- Sponsor
- Assiut University
- Start
- Mar 2016
- Primary completion
- Aug 2017
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of nitroglycerin in hemorrhagic shock (2 arms), sponsored by Assiut University. Primary endpoint: Perfusion Index at 48 hours. Status: unknown.
02
Drugs
nitroglycerin
03
Conditions
hemorrhagic shock
Beyond the preview
Go deeper on NCT03235921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03235921.